Differentiation of lipoedema from bilateral lower limb lymphoedema by imaging assessment of indocyanine green lymphography.
lip
lymphatic vessels
oedema
oedemaindocyanine green lymphography
Journal
Clinical obesity
ISSN: 1758-8111
Titre abrégé: Clin Obes
Pays: England
ID NLM: 101560587
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
revised:
30
01
2023
received:
12
12
2022
accepted:
04
02
2023
medline:
5
5
2023
pubmed:
24
2
2023
entrez:
23
2
2023
Statut:
ppublish
Résumé
Lipoedema is characterized by disproportionate painful fat accumulation mostly in the lower limbs. The presence of lymphoedema in lipoedema remains controversial. This study aimed to assess the presence or absence of lymphoedema in the lower limbs of women with lipoedema using indocyanine green (ICG) lymphography. A cross-sectional retrospective study was undertaken in women with a clinical diagnosis of lipoedema whose lower limbs were examined with ICG lymphography. MD Anderson Cancer Center (MDACC) ICG staging was used to determine lymphoedema presence and severity. Patient characteristics, ICG lymphography findings, Stemmer sign, body mass index, waist-to-hip ratio, limb volume and bioimpedance spectroscopy measures were recorded. Forty women with lipoedema underwent ICG lymphography for the lower limbs from January 2018 to July 2022. Thirty-four women (85.0%) were determined by ICG lymphography as MDACC ICG Stage 0 representing normal lymphatics. Of the six women who demonstrated dermal backflow on ICG lymphography, all were determined as ICG Stage 1, four had localized traumatic dermal backflow area at their ankles, one had previously diagnosed with primary lymphoedema and one was classified as lipoedema stage 4. ICG lymphography findings suggested the absence of lymphoedema in a clear majority of women with lower limb lipoedema.
Substances chimiques
Indocyanine Green
IX6J1063HV
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12588Informations de copyright
© 2023 The Authors. Clinical Obesity published by John Wiley & Sons Ltd on behalf of World Obesity Federation.
Références
Allen EV, Hines EA. Lipoedema of the legs: a syndrome characterized by fat legs and orthostatic edema. Proc Staff Meet Mayo Clinic. 1940;15:184-187.
Halk AB, Damstra RJ. First Dutch guidelines on lipoedema using the international classification of functioning, disability and health. Phlebology. 2017;32(3):152-159.
Forner-Cordero I, Szolnoky G, Forner-Cordero A, Kemény L. Lipoedema: an overview of its clinical manifestations, diagnosis and treatment of the disproportional fatty deposition syndrome - systematic review. Clin Obes. 2012;2(3-4):86-95.
Bertsch A, Erbacher G. Lipoedema - myths and facts, part 2. Phlebologie. 2018;47:120-126.
Hamatschek M, Knors H, Klietz ML, et al. Characteristics and patient reported outcome measures in lipoedema patients-establishing a baseline for treatment evaluation in a high-volume center. J Clin Med. 2022;11(10):2836.
Grigoriadis D, Sackey E, Riches K, et al. Investigation of clinical characteristics and genome associations in the ‘UK Lipoedema’ cohort. PLoS One. 2022;17(10):e0274867.
World Health Organisation. International Classification of Diseases 11th Revision. Published 2018. https://www.who.int/standards/classifications/classification-of-diseases
Fife CE, Maus EA, Carter MJ. Lipoedema: a frequently misdiagnosed and misunderstood fatty deposition syndrome. Adv Skin Wound Care. 2010;23(2):81-92.
Warren Peled A, Kappos EA. Lipoedema: diagnostic and management challenges. Int J Womens Health. 2016;8:389-395.
Wold LE, Hines EA Jr, Allen EV. Lipoedema of the legs; a syndrome characterized by fat legs and edema. Ann Intern Med. 1951;34(5):1243-1250.
Herbst KL. Rare adipose disorders (RADs) masquerading as obesity. Acta Pharmacol Sin. 2012;33(2):155-172.
Herbst KL, Kahn LAE, Iker E, et al. Letter to the editor regarding lipoedema - myths and facts, part 1 and part 5. European best practice of lipoedema - summary of the European lipoedema forum consensus. Phlebologie. 2020;49:31-49.
Bertsch T, Erbacher G, Elwell R. Lipoedema: a paradigm shift and consensus. J Wound Care. 2020;29(Sup11b):1-51.
Kruppa P, Georgiou I, Biermann N, Prantl L, Klein-Weigel P, Ghods M. Lipoedema-pathogenesis, diagnosis, and treatment options. Dtsch Arztebl Int. 2020;117(22-23):396-403.
Greene AK, Sudduth CL. Lower extremity lymphatic function predicted by body mass index: a lymphoscintigraphic study of obesity and lipoedema. Int J Obes. 2021;45(2):369-373.
Mihara M, Hara H, Araki J, et al. Indocyanine green (ICG) lymphography is superior to lymphoscintigraphy for diagnostic imaging of early lymphoedema of the upper limbs. PLoS One. 2012;7(6):e38182.
Taylor R, Jayasinghe UW, Koelmeyer L, Ung O, Boyages J. Reliability and validity of arm volume measurements for assessment of lymphoedema. Phys Ther. 2006;86(2):205-214.
Ward LC. Bioelectrical impedance spectrometry for the assessment of lymphoedema: principles and practice. In: Greene AK, Slavin SA, Brorson H, eds. Lymphoedema: Presentation, Diagnosis, and Treatment. Springer International Publishing; 2015:123-132.
Stemmer R. A clinical symptom for the early and differential diagnosis of lymphoedema. Vasa. 1976;5(3):261-262.
Stemmer R. Stemmer's sign-possibilities and limits of clinical diagnosis of lymphedema. Wien Med Wochenschr. 1999;149(2-4):85-86.
Koelmeyer LA, Thompson BM, Mackie H, et al. Personalizing conservative lymphoedema management using indocyanine green-guided manual lymphatic drainage. Lymphat Res Biol. 2021;19(1):56-65.
Suami H, Thompson B, Mackie H, et al. A new indocyanine green fluorescence lymphography protocol for diagnostic assessment of lower limb lymphoedema. J Plast Reconstr Aesthet Surg. 2022;75(11):3946-3955.
Shinaoka A, Koshimune S, Suami H, et al. Lower-limb lymphatic drainage pathways and lymph nodes: a CT lymphangiography cadaver study. Radiology. 2020;294(1):223-229.
Nguyen AT, Suami H, Hanasono MM, Womack VA, Wong FC, Chang EI. Long-term outcomes of the minimally invasive free vascularized omental lymphatic flap for the treatment of lymphoedema. J Surg Oncol. 2017;115(1):84-89.
Jørgensen MG, Toyserkani NM, Hansen FCG, Thomsen JB, Sørensen JA. Prospective validation of indocyanine green lymphangiography staging of breast cancer-related lymphoedema. Cancers. 2021;13(7):1540.
Reich-Schupke S, Altmeyer P, Stücker M. Thick legs - not always lipoedema. J Dtsch Dermatol Ges. 2013;11(3):225-233.
Sudduth CL, Greene AK. Current overview of obesity-induced lymphoedema. Adv Wound Care. 2021;11(7):392-398.
Waki M, Kral JG, Mazariegos M, Wang J, Pierson RN Jr, Heymsfield SB. Relative expansion of extracellular fluid in obese vs. nonobese women. Am J Physiol. 1991;261(2):E199-E203.
Seidel AC, Belczak CE, Campos MB, Campos RB, Harada DS. The impact of obesity on venous insufficiency. Phlebology. 2015;30(7):475-480.
Moffatt CJ, Keeley V, Hughes A, et al. LIMPRINT: the UK experience-subjective control of swelling in patients attending specialist lymphoedema services. Lymphat Res Biol. 2019;17(2):211-220.
Buso G, Favre L, Maufus M, et al. Indocyanine green lymphography as novel tool to assess lymphatics in patients with lipoedema. Microvasc Res. 2022;140:104298.
Rasmussen JC, Aldrich MB, Fife CE, Herbst KL, Sevick-Muraca EM. Lymphatic function and anatomy in early stages of lipoedema. Obesity. 2022;30(7):1391-1400.
Zaleska MT, Olszewski WL, Krzesniak NE. Lower limb lipoedema-superficial lymph flow, skin water concentration, skin and subcutaneous tissue elasticity. Lymphat Res Biol. 2022. Epub ahead of print.
Weiler M, Kassis T, Dixon JB. Sensitivity analysis of near-infrared functional lymphatic imaging. J Biomed Opt. 2012;17(6):066019.
Cornely ME, Hasenberg T, Cornely OA, Ure C, Hettenhausen C, Schmidt J. Persistent lipoedema pain in patients after bariatric surgery: a case series of 13 patients. Surg Obes Relat Dis. 2022;18(5):628-633.